Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

NCT00647634 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Alprazolam Extended-Release Tablets 3 mg
DRUG: Xanax XR® Tablets (3 mg

Sponsor

Mylan Pharmaceuticals Inc